|
1) Ronco C. Cardiorenal syndromes: definition and classification. Contrib Nephrol. 2010; 164: 33-8
|
|
|
|
2) Nguyen MT, Devarajan P. Biomarkers for the early detection of acute kidney injury. Pediatr Nephrol. 2008; 23: 2151-7
|
|
|
|
|
3) Nielsen SE, Schjoedt KJ, Astrup AS, et al. Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross-sectional study and the effects of lisinopril. Diabet Med. 2010; 27: 1144-50
|
|
|
|
|
|
4) Koyner JL, Bennett MR, Worcester EM, et al. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int. 2008; 74: 1059-69
|
|
|
|
|
|
5) Liangos O, Perianayagam MC, Vaidya VS, et al. Urinary N-acetyl-beta (D)-glucosaminidase activity and kidney injury molecule-1 level are associated with adverse outcomes in acute renal failure. J Am Soc Nephrol. 2007; 18: 904-12
|
|
|
|
|
|
6) Nijboer WN, Schuurs TA, Damman J, et al. Kidney injury molecule-1 is an early noninvasive indicator for donor brain death-induced injury prior to kidney transplantation. Am J Transplant. 2009; 9: 1752-9
|
|
|
|
|
|
7) Nielsen SE, Sugaya T, Tarnow L, et al. Tubular and glomerular injury in diabetes and the impact of ACE inhibition. Diabetes Care. 2009; 32: 1684-8
|
|
|
|
|
|
8) Portilla D, Dent C, Sugaya T, et al. Liver fatty acid-binding protein as a biomarker of acute kidney injury after cardiac surgery. Kidney Int. 2008; 73: 465-72
|
|
|
|
|
|
9) Nakamura T, Sugaya T, Node K, et al. Urinary excretion of liver-type fatty acid-binding protein in contrast medium-induced nephropathy. Am J Kidney Dis. 2006; 47: 439-44
|
|
|
|
|
|
10) Nakamura T, Sugaya T, Koide H. Urinary liver-type fatty acid-binding protein in septic shock-Effect of polymyxin B-immobilized fiber hemoperfusion. SHOCK. 2009; 31: 454-9
|
|
|
|
|
|
11) Doi K, Noiri E, Maeda-Mamiya R, et al. Urinary L-type fatty acid-binding protein as a new biomarker of sepsis complicated with acute kidney injury. Crit Care Med. 2010; 38: 2037-42
|
|
|
|
|
|
12) Yamamoto T, Noiri E, Ono Y, et al. Renal L-type fatty acid-binding protein in acute ischemic injury. J Am Soc Nephrol. 2007; 18: 2894-902
|
|
|
|
|
|
13) Hall IE, Yarlagadda SG, Coca SG, et al. IL-18 and urinary NGAL predict dialysis and graft recovery after kidney transplantation. J Am Soc Nephrol. 2010; 21: 189-97
|
|
|
|
|
|
14) Kobayashi N, Karisola P, Pen-a-Cruz V, et al. TIM-1 and TIM-4 glycoproteins bind phosphatidylserine and mediate uptake of apoptotic cells. Immunity. 2007; 27: 927-40
|
|
|
|
|
|
15) Pennemans V, De Winter LM, Faes C, et al. Effect of pH on the stability of kidney injury molecule 1 (KIM-1) and on the accuracy of its measurement in human urine. Clin Chim Acta. 2010; 411: 2083-6
|
|
|
|
|
|
16) Ferguson MA, Vaidya VS, Waikar SS, et al. Urinary liver-type fatty acid-binding protein predicts adverse outcomes in acute kidney injury. Kidney Int. 2010; 77: 708-14
|
|
|
|
|
|
17) McMahon BA, Murray PT. Urinary liver fatty acid-binding protein: another novel biomarker of acute kidney injury. Kidney Int. 2010; 77: 657-9. Review
|
|
|
|
|
|
18) von Eynatten M, Baumann M, Heemann U, et al. Urinary L-FABP and anaemia: distinct roles of urinary markers in type 2 diabetes. Eur J Clin Invest. 2010; 40: 95-102
|
|
|
|
|
|
19) Nielsen SE, Sugaya T, Hovind P, et al. Urinary liver-type fatty acid-binding protein (u-LFABP) predicts progression to nephropathy in type 1 diabetic patients. Diabetes Care. 2010; 33: 1320-4
|
|
|
|
|
|
20) Liangos O, Tighiouart H, Perianayagam MC, et al. Comparative analysis of urinary biomarkers for early detection of acute kidney injury following cardiopulmonary bypass. Biomarkers. 2009; 14: 423-31
|
|
|
|
|
|
21) Moore E, Bellomo R, Nichol A. Biomarkers of acute kidney injury in anesthesia, intensive care and major surgery: from the bench to clinical research to clinical practice. Minerva Anestesiol. 2010; 76: 425-40. Review
|
|
|
|
|
|
22) Che M, Xie B, Xue S, et al. Clinical usefulness of novel biomarkers for the detection of acute kidney injury following elective cardiac surgery. Nephron Clin Pract. 2010; 115: c66-72
|
|
|
|
|
|
23) Han WK, Wagener G, Zhu Y, et al. Urinary biomarkers in the early detection of acute kidney injury after cardiac surgery. Clin J Am Soc Nephrol. 2009; 4: 873-82
|
|
|
|
|
|
24) Yokoyama H, Sone H, Oishi M, et al. Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15). Nephrol Dial Transplant. 2009; 24: 1212-9
|
|
|
|
|
|
25) Kamijo-Ikemori A, Sugaya T, Kimura K. Urinary fatty acid binding protein in renal disease. Clin Chim Acta. 2006; 374: 1-7
|
|
|
|
|
|
26) Noiri E, Doi K, Negishi K, et al. Urinary fatty acid binding protein 1: An early predictive biomarker of kidney injury. Am J Physiol Renal Physiol. 2009; 296: 669-79
|
|
|
|
|